Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina
- PMID: 15219943
- DOI: 10.1016/j.canlet.2004.04.011
Investigation of genetic polymorphisms and smoking in a bladder cancer case-control study in Argentina
Abstract
We investigated the role of glutathione S-transferase (GST) enzymes (M1, T1), methylenetetrahydrofolate (MTHFR) 677 and 1298, and the NAD(P)H:quinone oxidoreductase (NQO1) polymorphisms in a population-based bladder cancer case-control study in Argentina. Buccal cell DNA was obtained from 106 cases and 109 controls. The strongest evidence was for an interaction between NQO1 genotype and smoking. For ever smoking vs. never smoking the odds ratio was 8.6 (95% confidence interval (CI) 2.7-27), in the CC genotype, and 1.3 (95% CI 0.5-3.5) in the CT and TT genotypes combined. Also, elevated bladder cancer risks associated with GSTM1 and GSTT1 null genotypes were found in smokers. Having both null polymorphisms conferred the highest risks. The MTHFR 677 CT and TT polymorphisms appeared protective against bladder cancer.
Similar articles
-
Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.Neoplasma. 1998;45(5):312-7. Neoplasma. 1998. PMID: 9921921
-
[Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case-control study].Zhonghua Zhong Liu Za Zhi. 2004 Nov;26(11):645-8. Zhonghua Zhong Liu Za Zhi. 2004. PMID: 15777499 Chinese.
-
Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.Cancer Lett. 2005 Feb 28;219(1):63-9. doi: 10.1016/j.canlet.2004.10.006. Cancer Lett. 2005. PMID: 15694665
-
Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review.Am J Epidemiol. 2002 Jul 15;156(2):95-109. doi: 10.1093/aje/kwf018. Am J Epidemiol. 2002. PMID: 12117698 Review.
-
Bladder cancer and smoking. Part 3: influence of perceptions and beliefs.Br J Nurs. 2008 Nov 13-26;17(20):1292-7. doi: 10.12968/bjon.2008.17.20.31649. Br J Nurs. 2008. PMID: 19043336 Review.
Cited by
-
The relationship between GSTA1, GSTM1, GSTP1, and GSTT1 genetic polymorphisms and bladder cancer susceptibility: A meta-analysis.Medicine (Baltimore). 2016 Sep;95(37):e4900. doi: 10.1097/MD.0000000000004900. Medicine (Baltimore). 2016. PMID: 27631264 Free PMC article.
-
Associations of MTHFR rs1801133 (677C>T) and rs180113 (1298A>C) Polymorphisms with Susceptibility to Bladder Cancer: A Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev. 2022 May 1;23(5):1465-1482. doi: 10.31557/APJCP.2022.23.5.1465. Asian Pac J Cancer Prev. 2022. PMID: 35633528 Free PMC article.
-
Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.Tumour Biol. 2014 Jul;35(7):6415-23. doi: 10.1007/s13277-014-1869-1. Epub 2014 Mar 28. Tumour Biol. 2014. PMID: 24676794
-
GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis.Oncotarget. 2017 Jan 10;8(2):3246-3258. doi: 10.18632/oncotarget.13702. Oncotarget. 2017. PMID: 27911277 Free PMC article.
-
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.Lancet. 2005 Aug 20-26;366(9486):649-59. doi: 10.1016/S0140-6736(05)67137-1. Lancet. 2005. PMID: 16112301 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous